This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

  • Home
  • Published Projects
  • Registries
Advanced Search

Study Preview



Study Title and Description

Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.



Key Questions Addressed
26 Heart Failure Guiding Question 1. Which specific consumer automated-entry PGHD applications/technologies/devices have been studied for measurement of health outcomes? What studies are in progress of consumer PGHD devices?
  • Comments Comments (
    0
    ) |
  • Post/View
27 Heart Failure Guiding Question 2. What are the characteristics (e.g., interoperability, functions, acceptability/usability, sustainability, feasibility, fidelity, or integration into electronic health records) of these specific consumer automated-entry PGHD technologies?
  • Comments Comments (
    0
    ) |
  • Post/View
28 Heart Failure Guiding Question 3. What is the influence of specific consumer automated-entry PGHD technologies on health outcomes? Does this vary across different patient populations, different settings, or other modifiers of effectiveness?
  • Comments Comments (
    0
    ) |
  • Post/View
29 Heart Failure Guiding Question 4. What are the harms or adverse events associated with these specific consumer automated-entry PGHD technologies? Which patients in which settings are most at risk of harms?
  • Comments Comments (
    0
    ) |
  • Post/View
30 Heart Failure Guiding Question 5. For the technologies demonstrating associations with outcomes of interest, what full economic evaluations provide information on the relative value for consumers?
  • Comments Comments (
    0
    ) |
  • Post/View

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial.
Author Koehler F., Koehler K., Deckwart O., Prescher S., Wegscheider K., Kirwan BA., Winkler S., Vettorazzi E., Bruch L., Oeff M., Zugck C., Doerr G., Naegele H., Störk S., Butter C., Sechtem U., Angermann C., Gola G., Prondzinsky R., Edelmann F., Spethmann S., Schellong SM., Schulze PC., Bauersachs J., Wellge B., Schoebel C., Tajsic M., Dreger H., Anker SD., Stangl K.
Country Centre for Cardiovascular Telemedicine, Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: friedrich.koehler@charite.de.
Year 2018
Numbers Pubmed ID: 30153985

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Heart Failure
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.